Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDerwent London Regulatory News (DLN)

Share Price Information for Derwent London (DLN)

Share Price is delayed by 15 minutes
Get Live Data
1,765.00    -13.00 (-0.73%)
Bid:
1,768.00
Ask:
1,771.00
Spread: 3.00 (0.17%)
Market Cap: £1.98b
DLN Live PriceLast checked at - London Stock Exchange

Intraday Derwent London Share Chart

Special Dividend

28 Feb 2017 07:03

RNS Number : 9926X
Derwent London PLC
28 February 2017
 

28 February 2017

 

 

Derwent London plc ("Derwent London" / "the Group")Special dividend

 

Following the announcement today of several value-enhancing transactions, the Directors of Derwent London are recommending a special dividend of 52p per share to be paid on 9 June 2017 to shareholders on the register as at 5 May 2017. 

 

The transactions announced today include £327m of property disposals above book value expected to complete before the end of June 2017, the pre-letting of 133,600 sq ft at 80 Charlotte Street W1 and the re-gear of leases at Angel Building to Expedia.

 

John Burns, Chief Executive Officer, commented:

"This special dividend takes account of today's other announcements, as well as the low gearing of the Group with a loan-to-value ratio of 17.7% as at 31 December 2016. We retain significant flexibility and firepower for the future including opportunities to make further acquisitions or to add to our pipeline of projects."

 

- ends -

 

Enquiries:

 

 Derwent London

 Tel +44 (0)20 7659 3000

 

John Burns, Chief Executive

Damian Wisniewski, Director

Quentin Freeman, Head of Investor Relations

 

 

 Brunswick Group LLP

 Tel: +44 (0)20 7404 5959

Tim Danaher

Emily Trapnell

 

 

 

 

Notes to editors

 

Derwent London plc

Derwent London plc owns a portfolio of commercial real estate predominantly in central London valued at £5.0 billion (including joint ventures) as at 31 December 2016, making it the largest London-focused real estate investment trust (REIT).

Our experienced team has a long track record of creating value throughout the property cycle by regenerating our buildings via development or refurbishment, effective asset management and capital recycling.

We typically acquire central London properties off-market with low capital values and modest rents in improving locations, most of which are either in the West End or the Tech Belt. We capitalise on the unique qualities of each of our properties - taking a fresh approach to the regeneration of every building with a focus on anticipating tenant requirements and an emphasis on design.

Reflecting and supporting our long-term success, the business has a strong balance sheet with modest leverage, a robust income stream and flexible financing.

Landmark schemes in our 6.0 million sq ft portfolio include Angel Building EC1, The Buckley Building EC1, White Collar Factory EC1, 1-2 Stephen Street W1, Horseferry House SW1 and Tea Building E1.

In 2016, the Group won the Estates Gazette National Company of the Year and London awards as well as awards from Architects' Journal, British Council for Offices, Civic Trust and RIBA and achieved EPRA Gold for corporate and sustainability reporting.

As part of its wider sustainability programme, in 2013 Derwent London launched a dedicated £250,000 voluntary Community Fund and, in 2016, made a further commitment of £300,000 for the next three years for Fitzrovia and the Tech Belt.

The Company is a public limited company, which is listed on the London Stock Exchange and incorporated and domiciled in the UK. The address of its registered office is 25 Savile Row, London, W1S 2ER.

For further information see www.derwentlondon.com or follow us on Twitter at @derwentlondon.

 

Forward-looking statements

This document contains certain forward-looking statements about the future outlook of Derwent London. By their nature, any statements about future outlook involve risk and uncertainty because they relate to events and depend on circumstances that may or may not occur in the future. Actual results, performance or outcomes may differ materially from any results, performance or outcomes expressed or implied by such forward-looking statements.

No representation or warranty is given in relation to any forward-looking statements made by Derwent London, including as to their completeness or accuracy. Derwent London does not undertake to update any forward-looking statements whether as a result of new information, future events or otherwise. Nothing in this announcement should be construed as a profit forecast.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DIVLFFFIFSIDFID
Date   Source Headline
2nd Jun 20262:00 pmRNSHolding(s) in Company
1st Jun 20267:00 amRNSTransaction in Own Shares
29th May 20265:37 pmRNSTotal Voting Rights
26th May 20267:00 amRNSTransaction in Own Shares
21st May 20265:15 pmRNSDirector/PDMR Shareholding
19th May 202610:00 amRNSDirector Declaration
18th May 20267:00 amRNSTransaction in Own Shares
15th May 202611:45 amRNSResult of AGM
12th May 20267:00 amRNSTrading Statement
1st May 202610:30 amRNSHolding(s) in Company
30th Apr 20264:45 pmRNSTotal Voting Rights
22nd Apr 20265:00 pmRNSHolding(s) in Company
22nd Apr 202610:15 amRNSHolding(s) in Company
20th Apr 202610:30 amRNSHolding(s) in Company
14th Apr 202611:14 amRNSAnnual Financial Report
10th Apr 20264:45 pmRNSAdmission to Trading
7th Apr 20265:12 pmRNSEmployee Benefit Trust (“EBT”)
7th Apr 20264:45 pmRNSDirector/PDMR Shareholding
2nd Apr 20267:00 amRNSAppointment of Barclays as joint corporate broker
1st Apr 20267:00 amRNSDisposal of Horseferry House SW1
31st Mar 20264:45 pmRNSTotal Voting Rights
27th Mar 202612:45 pmRNSDirector/PDMR Shareholding
24th Mar 202610:30 amRNSDirector/PDMR Shareholding
20th Mar 20264:15 pmRNSDirector/PDMR Shareholding
16th Mar 20267:00 amRNSNetwork building fully pre-let
16th Mar 20267:00 amRNSNetwork building fully pre-let
27th Feb 20264:45 pmRNSTotal Voting Rights
26th Feb 20267:32 amRNSDerwent London plc Disposal of 90 Whitfield Street
26th Feb 20267:00 amRNSResults for the Year Ended 31 December 2025
6th Feb 20264:40 pmRNSHolding(s) in Company
6th Feb 20267:00 amRNSDisposal of 80-85 Tottenham Court Road W1
30th Jan 20264:45 pmRNSTotal Voting Rights
22nd Jan 20269:00 amRNSDirectorate change
15th Jan 202611:00 amRNSHolding(s) in Company
31st Dec 20251:15 pmRNSTotal Voting Rights
31st Dec 20251:15 pmRNSTotal Voting Rights
17th Dec 20257:00 amRNSPlanning success at Blue Star House SW9
9th Dec 20257:00 amRNSBurberry extends commitment to Horseferry House
28th Nov 20254:45 pmRNSTotal Voting Rights
6th Nov 20257:00 amRNSThird Quarter Business Update
31st Oct 20254:45 pmRNSTotal Voting Rights
21st Oct 20257:00 amRNSStrategic partnership at Old Street Quarter
9th Oct 20257:00 amRNSSuccessful completion of 25 Baker Street
30th Sep 20254:45 pmRNSTotal Voting Rights
30th Sep 202511:00 amRNSHolding(s) in Company
22nd Sep 202512:00 pmRNSBlock listing Interim Review
9th Sep 202511:45 amRNSDirector Declaration
2nd Sep 202511:30 amRNSHolding(s) in Company
29th Aug 20254:45 pmRNSTotal Voting Rights
12th Aug 20257:00 amRNSBoard Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.